• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Thursday

    7/20/23 2:01:19 PM ET
    $ACGN
    $APLS
    $APM
    $ASTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACGN alert in real time by email

     

    During Thursday's session, 40 stocks hit new 52-week lows.

    52-Week Low Highlights:

    • The largest company by market cap to set a new 52-week low was Crown Castle (NYSE:CCI).
    • The smallest company by market cap to set a new 52-week low was Ucommune International (NASDAQ:UK).
    • Vir Biotechnology (NASDAQ:VIR)'s stock fell the most, as it traded down 44.38% to reach a new 52-week low.
    • Yunji (NASDAQ:YJ)'s stock rebounded the most, as it traded up 0.0% after dropping to a new 52-week low.

    Here are all the stocks that set new 52-week lows on Thursday:

    • Crown Castle (NYSE:CCI) shares set a new 52-week low of $103.22. The stock traded down 5.62%.
    • Kenvue (NYSE:KVUE) stock broke to a new 52-week low of $22.49 on Thursday. Shares of the company traded down 3.06%.
    • SBA Comms (NASDAQ:SBAC) stock drifted down 7.65% on Thursday morning to hit a new 52-week low of $214.56.
    • NovoCure (NASDAQ:NVCR) shares set a new 52-week low of $38.29. The stock traded up 0.28%.
    • Apellis Pharmaceuticals (NASDAQ:APLS) stock set a new 52-week low of $34.71 on Thursday, moving down 12.81%.
    • Cedar Fair (NYSE:FUN) stock hit a yearly low of $36.44. The stock was down 1.21% for the day.
    • Vir Biotechnology (NASDAQ:VIR) shares reached a new 52-week low of $12.56 on Thursday morning, moving down 44.38%.
    • Nu Skin Enterprises (NYSE:NUS) stock hit a new 52-week low of $28.50. The stock was down 1.73% on the session.
    • Monro (NASDAQ:MNRO) stock hit a yearly low of $38.21. The stock was down 0.94% for the day.
    • SIGNA Sports United (NYSE:SSU) stock drifted down 5.22% on Thursday morning to hit a new 52-week low of $2.51.
    • Silk Road Medical (NASDAQ:SILK) shares hit a yearly low of $19.93. The stock was down 1.76% on the session.
    • Beneficient (NASDAQ:BENF) stock hit a new 52-week low of $2.16. The stock was down 10.7% on the session.
    • uniQure (NASDAQ:QURE) shares hit a yearly low of $10.08. The stock was down 0.1% on the session.
    • Sohu.com (NASDAQ:SOHU) shares moved down 0.78% on Thursday to hit a new 52-week low of $10.73, drifting down 0.78%.
    • FibroGen (NASDAQ:FGEN) shares were down 2.58% for the day, having made a 52-week low of $2.29.
    • Richardson Electronics (NASDAQ:RELL) stock achieved a new 52-week low on Thursday morning, hitting $12.80 and moving down 10.83%.
    • NioCorp Developments (NASDAQ:NB) shares made a new 52-week low of $4.57 on Thursday. The stock was down 2.66% for the day.
    • OrganiGram Holdings (NASDAQ:OGI) stock achieved a new 52-week low on Thursday morning, hitting $1.34 and moving down 4.96%.
    • Destra Multi-Alternative (NYSE:DMA) shares reached a new 52-week low of $4.82 on Thursday morning, moving down 1.01%.
    • Yunji (NASDAQ:YJ) shares hit a yearly low of $1.21. The stock was 0.0% (flat) on the session.
    • Aspira Womens Health (NASDAQ:AWH) shares were down 31.66% for the day, having made a 52-week low of $2.62.
    • Strong Global (AMEX:SGE) shares set a new 52-week low of $2.70. The stock traded down 0.84%.
    • Golden Sun Education Gr (NASDAQ:GSUN) stock drifted up 2.28% on Thursday morning to hit a new 52-week low of $0.91.
    • AERWINS Technologies (NASDAQ:AWIN) shares hit a yearly low of $0.27. The stock was down 9.02% on the session.
    • ShiftPixy (NASDAQ:PIXY) shares hit a yearly low of $1.23. The stock was down 6.9% on the session.
    • Treasure Global (NASDAQ:TGL) shares set a new yearly low of $0.72 this morning. The stock was down 2.99% on the session.
    • Aceragen (NASDAQ:ACGN) shares reached a new 52-week low of $1.21 on Thursday morning, moving down 13.19%.
    • Aptorum Gr (NASDAQ:APM) shares made a new 52-week low of $2.09 on Thursday. The stock was down 0.96% for the day.
    • JE Cleantech Hldgs (NASDAQ:JCSE) shares were down 5.39% for the day, having made a 52-week low of $0.41.
    • Mallinckrodt (AMEX:MNK) stock hit a yearly low of $0.56. The stock was down 13.75% for the day.
    • Ascent Solar Technologies (NASDAQ:ASTI) shares hit a yearly low of $0.08. The stock was down 2.37% on the session.
    • 9 Meters Biopharma (NASDAQ:NMTR) stock drifted down 7.44% on Thursday morning to hit a new 52-week low of $0.15.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ACGN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACGN
    $APLS
    $APM
    $ASTI

    CompanyDatePrice TargetRatingAnalyst
    Six Flags Entertainment Corporation
    $FUN
    2/5/2026$20.00Buy → Neutral
    Citigroup
    Kenvue Inc.
    $KVUE
    1/30/2026$18.00Buy → Hold
    Jefferies
    uniQure N.V.
    $QURE
    1/28/2026$31.00Equal Weight
    Barclays
    Apellis Pharmaceuticals Inc.
    $APLS
    1/28/2026$24.00Equal Weight
    Barclays
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Apellis Pharmaceuticals Inc.
    $APLS
    1/21/2026$28.00Neutral → Buy
    BofA Securities
    Crown Castle Inc.
    $CCI
    1/5/2026$93.00Buy → Neutral
    New Street
    Crown Castle Inc.
    $CCI
    12/1/2025$101.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $ACGN
    $APLS
    $APM
    $ASTI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Fitzsimmons Peter D bought $251,017 worth of shares (13,350 units at $18.80), increasing direct ownership by 16% to 99,283 units (SEC Form 4)

    4 - MONRO, INC. (0000876427) (Issuer)

    2/5/26 3:32:45 PM ET
    $MNRO
    Automotive Aftermarket
    Consumer Discretionary

    Director Smith Jeffrey C bought $110,986,526 worth of shares (6,377,694 units at $17.40) (SEC Form 4)

    4 - Kenvue Inc. (0001944048) (Issuer)

    12/15/25 4:00:25 PM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    CEO Wettig Thane bought $33,750 worth of shares (3,700 units at $9.12), increasing direct ownership by 17% to 24,939 units (SEC Form 4)

    4 - FIBROGEN INC (0000921299) (Issuer)

    11/17/25 4:42:52 PM ET
    $FGEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACGN
    $APLS
    $APM
    $ASTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO, CAO, Corporate Secretary Ben Robert J sold $59,503 worth of shares (5,000 units at $11.90), decreasing direct ownership by 8% to 57,034 units (SEC Form 4)

    4 - RICHARDSON ELECTRONICS, LTD. (0000355948) (Issuer)

    2/6/26 10:11:09 AM ET
    $RELL
    Electronic Components
    Technology

    Chief Executive Officer Francois Cedric exercised 8,840 shares at a strike of $3.76, increasing direct ownership by 2% to 490,837 units (SEC Form 4)

    4 - Apellis Pharmaceuticals, Inc. (0001492422) (Issuer)

    2/5/26 4:14:07 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Fitzsimmons Peter D bought $251,017 worth of shares (13,350 units at $18.80), increasing direct ownership by 16% to 99,283 units (SEC Form 4)

    4 - MONRO, INC. (0000876427) (Issuer)

    2/5/26 3:32:45 PM ET
    $MNRO
    Automotive Aftermarket
    Consumer Discretionary

    $ACGN
    $APLS
    $APM
    $ASTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness

    The updated edition of the New York Times bestseller from the chair of the Nu Skin Scientific Advisory Board reveals latest science behind measurable biology and evidence-based longevity Nu Skin Enterprises Inc. (NYSE:NUS) today announced the relaunch of "The Aging Myth: Unlocking the Mysteries of Looking and Feeling Young," the updated edition of the bestselling book from Dr. Joseph Chang, chair of Nu Skin's Scientific Advisory Board. The relaunch marks a significant milestone in the evolution of evidence-based beauty and wellness, bringing together decades of research that underpin Nu Skin's science-led innovations — from ageLOC® technology to the company's intelligent beauty and wellne

    2/6/26 1:56:00 PM ET
    $NUS
    Other Pharmaceuticals
    Health Care

    uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

    ~ Supraphysiological expression of α-Gal A activity maintained for over a year in longest treated patient as of data cutoff date ~ ~ Stable Lyso-Gb3 levels maintained post-dosing, regardless of enzyme replacement therapy status across all cohorts ~ ~ Six of 11 patients have discontinued enzyme replacement therapy as of data cutoff date ~ LEXINGTON, Mass. and AMSTERDAM, Feb. 06, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced updated preliminary safety and exploratory efficacy data from 11 patients in its Phase I/IIa trial of AMT-191, an investigational AAV gene

    2/6/26 7:05:00 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SPEEDWAY STUNT COASTER NOW OPEN AT SIX FLAGS MÉXICO

    New Coaster is a Celebration of Adrenaline and Family Fun Photo and logo assets available HERE CHARLOTTE, N.C., Feb. 6, 2026 /PRNewswire/ -- Six Flags Entertainment Corporation (NYSE:FUN), North America's largest regional amusement park operator, today announced the debut of Speedway Stunt Coaster at Six Flags México. The park recently celebrated the grand opening of its new family boomerang roller coaster with a major celebration where hundreds of guests were among the first to experience this exciting new attraction. Speedway Stunt Coaster has quickly become one of the park'

    2/6/26 6:01:00 AM ET
    $FUN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ACGN
    $APLS
    $APM
    $ASTI
    SEC Filings

    View All

    SEC Form 10-Q filed by NioCorp Developments Ltd.

    10-Q - NIOCORP DEVELOPMENTS LTD (0001512228) (Filer)

    2/6/26 4:36:49 PM ET
    $NB
    Metal Mining
    Basic Materials

    SEC Form 6-K filed by Aptorum Group Limited

    6-K - Aptorum Group Ltd (0001734005) (Filer)

    2/6/26 4:00:16 PM ET
    $APM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NovoCure Limited filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - NovoCure Ltd (0001645113) (Filer)

    2/5/26 8:00:26 AM ET
    $NVCR
    Medical/Dental Instruments
    Health Care

    $ACGN
    $APLS
    $APM
    $ASTI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    FDA Approval for EMPAVELI issued to APELLIS PHARMACEUTICALS INC

    Submission status for APELLIS PHARMACEUTICALS INC's drug EMPAVELI (ORIG-1) with active ingredient PEGCETACOPLAN has changed to 'Approval' on 05/14/2021. Application Category: NDA, Application Number: 215014, Application Classification: Type 1 - New Molecular Entity

    5/17/21 11:09:40 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACGN
    $APLS
    $APM
    $ASTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Six Flags Entertainment downgraded by Citigroup with a new price target

    Citigroup downgraded Six Flags Entertainment from Buy to Neutral and set a new price target of $20.00

    2/5/26 6:59:51 AM ET
    $FUN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Kenvue downgraded by Jefferies with a new price target

    Jefferies downgraded Kenvue from Buy to Hold and set a new price target of $18.00

    1/30/26 6:43:10 AM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    Barclays initiated coverage on uniQure with a new price target

    Barclays initiated coverage of uniQure with a rating of Equal Weight and set a new price target of $31.00

    1/28/26 7:20:10 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACGN
    $APLS
    $APM
    $ASTI
    Financials

    Live finance-specific insights

    View All

    Global Race for Critical Minerals Accelerates as Market Eyes $700B Opportunity by 2030

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Critical minerals are becoming one of the most important building blocks of the global economy. Materials like lithium, nickel, cobalt, rare earth elements, and graphite are essential for electric vehicles, renewable energy systems, data centers, smartphones, and defense technologies. As the world shifts toward electrification and clean energy, demand for these minerals is rising quickly, making them a strategic priority for governments and a growing focus for investors while keeping watch on Active Companies that include: North American Niobium (OTCQB:NIOMF) (CSE:NIOB), NioCorp Developments Ltd. (NASDAQ:NB),

    2/5/26 8:45:00 AM ET
    $MP
    $NB
    Metal Mining
    Basic Materials

    Crown Castle Reports Fourth Quarter and Full Year 2025 Results and Provides Outlook for Full Year 2026

    HOUSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE:CCI) ("Crown Castle") today reported results for the full year ended December 31, 2025 and issued its full year 2026 outlook, as reflected in the table below.  Full Year 2026 Full Year 2025(dollars in millions, except per share amounts)Current Outlook Midpoint(a)Midpoint GrowthRate Compared to Full Year 2025 Actual ActualActual Growth Rate Compared to Full Year 2024 ActualSite rental revenues(b)$3,850(5)% $4,049(5)%Net income (loss)$78076% $444N/ANet income (loss) per share—diluted$1.8078% $1.01N/AAdjusted EBITDA(b)(c)$2,690(6)% $2,863(6)%AFFO(b)(c)$1,9201% $1,904(4)%AFFO per share(b)(c)$4.432% $4.36(4)% (a)Reflects midpoi

    2/4/26 4:15:00 PM ET
    $CCI
    Real Estate Investment Trusts
    Real Estate

    Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026

    Kenvue Inc. (NYSE:KVUE) will announce its fourth quarter and full year 2025 financial results after market close on February 17, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its financial results. The press release will be available on the company's website at investors.kenvue.com. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue,

    2/4/26 6:45:00 AM ET
    $KVUE
    Specialty Chemicals
    Consumer Discretionary

    $ACGN
    $APLS
    $APM
    $ASTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by JE Cleantech Holdings Limited

    SC 13D/A - JE Cleantech Holdings Ltd (0001905511) (Subject)

    11/25/24 6:13:31 AM ET
    $JCSE
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Apellis Pharmaceuticals Inc.

    SC 13G/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 4:16:13 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACGN
    $APLS
    $APM
    $ASTI
    Leadership Updates

    Live Leadership Updates

    View All

    Richardson Electronics' Canvys Division Appoints Rainer Bornwasser as VP of Global Sales

    LAFOX, Ill., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Richardson Electronics, Ltd. (NASDAQ:RELL), today announced that Rainer Bornwasser has been appointed Vice President of Global Sales for Canvys – Visual Technology Solutions, a division of Richardson Electronics, effective February 1, 2026. The appointment underscores Richardson Electronics' commitment to accelerating global growth, expanding strategic OEM partnerships, and strengthening its position in high-value medical and industrial display markets through its Canvys division. For conference questions and registration information, please contact your Benchmark representative. Mr. Bornwasser brings more than 30 years of international sales

    2/3/26 11:00:00 AM ET
    $RELL
    Electronic Components
    Technology

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    Beneficient Appoints Peter T. Cangany Jr. as Chairman of the Board

    DALLAS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced that its Board of Directors (the "Board") has appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025. Mr. Cangany has served as a director of Beneficient and as Chairman of its independent Audit Committee since 2019. He brings decades of leadership experience in financial reporting, accounting, and corporate governance within the financial services industry. Mr. Cangany retired as a partner

    12/17/25 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance